360 filings
Page 10 of 18
8-K
trk6pyrfy2m922f6axe
1 Mar 13
Dynavax Reports Fourth Quarter and Year End 2012
12:00am
8-K
uauvh
1 Mar 13
Departure of Directors or Certain Officers
12:00am
8-K
ypzzsi9 09fppj
26 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
htaqurv rrarewlw
25 Feb 13
Dynavax Receives Fda Complete Response Letter on Heplisavtm Biologic License Application
12:00am
8-K
mkcjif20cn9n3 ay1v4
7 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
9ad0og
5 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
dkfxkf00u
19 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
v6lx6 xitm
15 Nov 12
Dynavax Announces Fda Advisory Committee Meeting Outcome
12:00am
8-K
t8q4y00kpe1
2 Nov 12
Dynavax Reports Third Quarter 2012 Financial Results
12:00am
8-K
smsflsvs2fctew s8pc
2 Nov 12
Departure of Directors or Certain Officers
12:00am
8-K
vo1ikd kli36m
1 Nov 12
Other Events
12:00am
8-K
cbut z2tw07wxp23
28 Aug 12
Other Events
12:00am
8-K
cq8immnbbmjm
23 Aug 12
Other Events
12:00am
8-K
46vbppxwo0jvipnjbqu
15 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
pd7hsxv6r8
1 Aug 12
Results of Operations and Financial Condition
12:00am
8-K
lmjq 692qwnca9eaxeqw
24 Jul 12
Other Events
12:00am
8-K
s2t07xbm
26 Jun 12
Other Events
12:00am
8-K
ari7z0rlw 95o3c3
1 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3bb 08wawlw0bft63c6z
10 May 12
Dynavax Announces Proposed Public Offering of Common Stock
12:00am
8-K
rbuo2d5 2fa3cf
8 May 12
Other Events
12:00am